Monoamine Oxidase Inhibitors

MAO-A

MAO-B

Monoamine Oxidase Inhibitors

Product Name	MAO-A	MAO-B	Purity
MAO-B-IN-25	MAO-A, IC₅₀: 240 nM	MAO-B, IC₅₀: 0.5 nM	99.11%
PSB-1434		MAO-B, IC₅₀: 1.59 nM
Tranylcypromine hydrochloride	MAO-A, IC₅₀: 2.3 μM	MAO-B, IC₅₀: 0.95 μM	99.51%
Selegiline hydrochloride		MAO-B, IC₅₀: 51 nM	99.85%
Pargyline	MAO-A, Ki: 13 μM	MAO-B, Ki: 0.5 μM	99.77%
Pargyline hydrochloride	MAO-A, Ki: 13 μM	MAO-B, Ki: 0.5 μM	99.91%
Moclobemide	MAO-A, IC₅₀: 6.061		99.90%
Rasagiline	rMAO-A, IC₅₀: 412 nM	rMAO-B, IC₅₀: 4.43 nM	99.88%
Norharmane	MAO-A, IC₅₀: 6.5 μM	MAO-B, IC₅₀: 4.7 μM	99.46%
Rasagiline mesylate	rMAO-A, IC₅₀: 412 nM	rMAO-B, IC₅₀: 4.43 nM	99.77%
Safinamide	MAO-A, IC₅₀: 580 μM	MAO-B, IC₅₀: 98 nM	99.89%
Harmane	hMAO-A, IC₅₀: 0.5 μM	MAO-B, IC₅₀: 5 μM	99.84%
MAO-IN-M30 dihydrochloride	MAO-A, IC₅₀: 37 nM	MAO-B, IC₅₀: 57 nM	99.25%
Safinamide mesylate	MAO-A, IC₅₀: 580 nM	MAO-B, IC₅₀: 98 nM	99.87%
Osthenol	hMAO-A, IC₅₀: 0.74 μM hMAO-A, Ki: 0.26 μM		99.27%
MAO-B-IN-18	hMAO-A, IC₅₀: 14 μM	hMAO-B, IC₅₀: 52 nM	99.84%
Bifemelane hydrochloride	MAO-A, Ki: 4.2 μM	MAO-B, Ki: 46 μM	98.83%
Methyl citrate		MAO-B, IC₅₀: 0.23 mM	≥98.0%
TC-2153	MAO-A		98.73%
Ladostigil hydrochloride		MAO-B, IC₅₀: 37.1 μM	99.94%
Chrysophanol-1-O-β-gentiobioside	MAO-A, IC₅₀: 96.15 μM		≥99.0%
Ladostigil hemitartrate		MAO-B, IC₅₀: 37.1 nM	98.90%
Ladostigil		MAO-B, IC₅₀: 37.1 μM
MAO-A/5-HT2AR-IN-1	MAO-A, IC₅₀: 0.004 ± 0. μM	MAO-B, IC₅₀: 1.05 ± 0.0 μM	99.71%
MAO A/HDAC-IN-1	MAO-A
CHBO4		hMAO-B, IC₅₀: 0.031 μM
Lazabemide hydrochloride		MAO-B, IC₅₀: 0.4 nM
MAO-B-IN-10	MAO-A, IC₅₀: 15.9 ± 0.1 μM	MAO-B, IC₅₀: 5.3 ± 0.22 μM
MAO-B-IN-8		MAO-B	98.03%
Befloxatone	MAO-A, IC₅₀: 4 nM	MAO-B, IC₅₀: 300 nM
1-Methyl-2-undecyl-4(1H)-quinolone		MAO-B, IC₅₀: 15.3 μM MAO-B, Ki: 9.91 μM
AChE-IN-60	MAO-A, IC₅₀: 353 nM	MAO-B, IC₅₀: 716 nM
Cimoxatone	MAO-A
PSB-1491		hMAO-B, IC₅₀: 0.0386 nM
Tetrindole mesylate	MAO-A
AChE/MAO-B-IN-3		hMAO-B, IC₅₀: 0.0456 μM
Dual AChE-MAO B-IN-3		MAO-B, IC₅₀: 0.41 ± 0.0 μM
AChE/MAO-B-IN-4		hMAO-B
Desoxypeganine	MAO-A, IC₅₀: 2 μM
Monoamine oxidase/Aromatase-IN-1		MAO-B, IC₅₀: 39 nM
MAO-B-IN-14		hMAO-B, IC₅₀: 0.95 μM hMAO-B, Ki: 0.55 μM
FTEAA	MAO-A, IC₅₀: 0.52 μM	MAO-B, IC₅₀: 1.02 μM
LSD1-IN-17	MAO-A, IC₅₀: 0.028 ± 0. μM	MAO-B, IC₅₀: 0.820 ± 0. μM
MAO-B-IN-3		MAO-B, IC₅₀: 96 nM
MAO-A inhibitor 1	MAO-A, IC₅₀: 100 μM
hAChE-IN-3		MAO-B, IC₅₀: 5.15 μM
AChE/BChE-IN-6		hMAO-B, IC₅₀: ＞ 100 μM
AChE/BChE/MAO-B-IN-2		MAO-B, IC₅₀: 48.2 nM
MAO-B-IN-11		MAO-B, IC₅₀: 1.3 μM
(±)-Amiflamine	MAO-A, pIC₅₀: 5.57		99.23%
HDAC1/MAO-B-IN-1		MAO-B, IC₅₀: 99.0 nM
LSD1-IN-12	MAO-A, Ki: 2.3 μM	MAO-B, Ki: 3.5 μM
1-Methyl-2-nonyl-4(1H)-quinolone	MAO-A	MAO-B
AChE/MAO-IN-1	hMAO-A, IC₅₀: 0.1108 μM hMAO-A, Ki: 0.1069 μM	hMAO-B, IC₅₀: 0.0409 μM
H3R antagonist 2		MAO-B, IC₅₀: 775 nM
SL-25.1188		hMAO-B, Ki: 2.9 nM rMAO-B, Ki: 8.5 nM
Monoamine Oxidase B inhibitor 1	MAO-A, IC₅₀: 810 nM	MAO-B, IC₅₀: 0.02 nM
MAO-B-IN-7		MAO-B, IC₅₀: 0.3 μM
Methyl piperate		MAO-B
MAO-B-IN-20	MAO-A, IC₅₀: >10 μM	MAO-B, IC₅₀: 0.037 μM
MAO-B-IN-19		MAO-B, IC₅₀: 0.67 μM
MAO-A inhibitor 2	MAO-A, IC₅₀: 14.3 μM	MAO-B, IC₅₀: 106 μM
AChE/BuChE/MAO-B-IN-2		hMAO-B, IC₅₀: 1.9 μM
LSD1-IN-16	MAO-A, IC₅₀: 0.024 ± μM	MAO-B, IC₅₀: 0.366 ± μM
hMAO-B-IN-7		hMAO-B, IC₅₀: 0.79 μM
Neuroinflammatory-IN-2		MAO-B, IC₅₀: 10.30 μM
MAO-B-IN-29		MAO-B
(E)-8-(3-Chlorostyryl)caffeine		MAO-B, Ki: 70 nM
AChE/BChE/MAO-B-IN-1		MAO-B, IC₅₀: 26.1 μM
Harmane (Standard)	hMAO-A	MAO-B
MAO-B-IN-6	MAO-A, IC₅₀: 46.365 μM	MAO-B, IC₅₀: 0.019 μM
Dual AChE-MAO B-IN-2		MAO-B, Ki: 4.5 μM
MAO-B-IN-30	MAO-A, IC₅₀: 19.176 μM	MAO-B, IC₅₀: 0.082 μM
MAO-B-IN-16	hMAO-A, IC₅₀: ＞100 μM	hMAO-B, IC₅₀: 1.55 μM
Selegiline		MAO-B, IC₅₀: 51 nM
AChE/BChE/MAO-B-IN-3		hMAO-B, IC₅₀: 0.0359 μM
LSD1-IN-15	MAO-A, IC₅₀: 0.028 ± 0. μM	MAO-B, IC₅₀: 0.327 ± 0. μM
MAO A/HSP90-IN-2	MAO-A, IC₅₀: 4.58 μM
5-HT6R/MAO-B modulator 1		MAO-B
MAO-B-IN-15	hMAO-A, IC₅₀: >100 μM	hMAO-B, IC₅₀: 13.5 μM
2-PAT	MAO-A, IC₅₀: 0.721 μM	MAO-B, IC₅₀: 14.6 μM
Monoamine Oxidase B inhibitor 2	MAO-A, IC₅₀: 1150 nM	MAO-B, IC₅₀: 1.33 nM
LSD1-IN-26	MAO-A, IC₅₀: 1234.57 nM	MAO-B, IC₅₀: 3819.27 nM
AChE/BuChE/MAO-B-IN-1		hMAO-B, IC₅₀: 1.11 μM
MAO A/HSP90-IN-1	MAO-A, IC₅₀: 1.77 μM
MAO-B-IN-12		MAO-B, IC₅₀: 1.3 μM
Eckol	hMAO-A, IC₅₀: 7.20 μM	hMAO-B, IC₅₀: 83.44 μM
MAO-B-IN-5	MAO-A, IC₅₀: 0.204 μM	MAO-B, IC₅₀: 34.190 μM
ASS234	MAO-A, IC₅₀: 5.2 nM	MAO-B, IC₅₀: 43 nM
MAO-B-IN-17	hMAO-A, IC₅₀: >100 μM	hMAO-B, IC₅₀: 5.08 μM	≥99.0%
AChE/MAO-IN-2	MAO-A, IC₅₀: 0.1116 μM	MAO-B, IC₅₀: 0.0412 μM
MAO-B-IN-21		MAO-B
MAO-B-IN-31		MAO-B, IC₅₀: 41 nM
hMAO-B-IN-2		MAO-B, IC₅₀: 4 nM
MAO-B-IN-13		MAO-B, IC₅₀: 10 nM
MAO-B-IN-9		MAO-B, IC₅₀: 0.178 ± 0. μM
Moclobemide N-Oxide	MAO-A

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。沪(浦)应急管危经许[2021]201709(QFYS)	站点地图隐私声明
Copyright © 2013-2024 MedChemExpress. All Rights Reserved.	沪ICP备15051369号-4

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。沪(浦)应急管危经许[2021]201709(QFYS)

站点地图隐私声明

Monoamine Oxidase Inhibitors

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

姓名
邮箱 *

Sorry, but the email address you supplied was invalid.